
How do NPS’s nanodrug particles differ from other nanodrugs?
- NPS Platform is based on physical vapor deposition (PVD) Technology
- NPS Makes drug nanoparticles with no excipients or solvents
- NPS nanodrug particles can be used in pills, nasal sprays, creams/salves, inhalers, eye drops, or injectable
- Universal application to all APIs that can be further processed into any existing dosage form
- Rapid development of nanoformulation using minimal amount of API
Services
7/7/70 – Feasibility Study – Generate Nanoparticles of your API
- Rapid development time of 7 weeks unlike nano-emulsion, nano-crystals, or lipid-nanoparticles
- Small development sample requirement of 7 grams unlike other enabling technologies
- Low development cost unlike other processes
- No chemicals, harsh solvents, or thermal degradation present in API nanoparticles.
- PVD on generic hydrophilic carrier for feasibility
- Analytical: Purity assay (Agilent 1100 Series HPLC) and particle size distribution (SHIMADZU SALD-2300)